Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Affiliations

• ¹ Clinical Cooperation Unit Molecular Haematology/Oncology, German Cancer Research Center (DKFZ) Heidelberg, Germany; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
• ² Clinical Cooperation Unit Molecular Haematology/Oncology, German Cancer Research Center (DKFZ) Heidelberg, Germany; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany; Department of Medical Oncology, National Center for Tumor Diseases (NCT), University of Heidelberg, Heidelberg, Germany.
• ³ Department of Pathology and Molecular Pathology, University Hospital Zurich (USZ), Zurich, Switzerland; Medical Faculty, University of Zurich (UZH), Zurich, Switzerland.
• ⁴ Medical Oncology Department, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy.
• ⁵ Division of Radiology, German Cancer Research Center (DKFZ), Heidelberg.
• ⁶ Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and Biomedical Center, Charles University, Pilsen, Czech Republic.
• ⁷ Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
• ⁸ Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
• ⁹ Department of Oncology, Geneva University Hospital, Geneva, Switzerland; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, USA.
• ¹⁰ Department of Cancer Medicine, Institute Gustave Roussy, University of Paris Saclay, Villejuif, France.
• ¹¹ Department of Cancer Medicine, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
• ¹² Department of Medical Oncology, University of Ioannina, Ioannina, Greece.
• ¹³ European Society for Medical Oncology, Lugano, Switzerland.